Product Information
SEVELAMER HCL 800 MG TABLET is a generic product labeled by NorthStar Rx LLC, priced at $1.0471 per EA under NDC 72603014801. Its NADAC has been published 121 times since Oct 11, 2023.
FDA first approved this application on Feb 8, 2019. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
The High Outlier badge above means this manufacturer's average price in the sevelamer hydrochloride market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
800 mg/1
Manufacturer
NorthStar Rx LLCNDC
72603014801
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
1/21/2026
Active Ingredients
SEVELAMER HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA204724FDA Approved
2/8/2019
TE Code
AB
On Market Since
5/23/2023
Pharmacological Classes
Price Statistics
The NADAC for SEVELAMER HCL 800 MG TABLET has been published 121 times since Oct 11, 2023, and over the history we have for it it has declined 55.1%. The table below summarizes its recorded NADAC range and movement.
| Current price | $1.0471 per EA |
|---|---|
| All-time high | $2.3333 (Nov 15, 2023) |
| All-time low | $1.0471 (Jan 21, 2026) |
| 52-week high | $1.3660 |
| 52-week low | $1.0471 |
| Median price | $1.3660 |
| Average price | $1.5013 |
| Largest weekly change | -37.7% (May 22, 2024) |
| Weeks tracked | 121 |
| Tracking since | Oct 11, 2023 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
-23.3%
3Y
N/A
5Y
N/A
All
-55.1%
Last surveyed Jan 28, 2026 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 34% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
NorthStar Rx LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
sevelamer hydrochloride market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Phosphate Binder class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of SEVELAMER HCL 800 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for SEVELAMER HCL 800 MG TABLET, manufactured by NorthStar Rx LLC, is $1.0471 per EA (NDC 72603014801), effective Jan 28, 2026.
How has the price of SEVELAMER HCL 800 MG TABLET changed over time?
Over the history we have for it, the NADAC for SEVELAMER HCL 800 MG TABLET has declined 55.1%. It has been tracked across 121 weekly CMS publications since Oct 11, 2023.
What are the highest and lowest recorded NADAC prices for SEVELAMER HCL 800 MG TABLET?
Since Oct 11, 2023, the NADAC for SEVELAMER HCL 800 MG TABLET has ranged from a low of $1.0471 (Jan 21, 2026) to a high of $2.3333 (Nov 15, 2023), with a median of $1.3660 per EA.
Are there cheaper alternatives to SEVELAMER HCL 800 MG TABLET?
Yes. 2 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, SEVELAMER HCL 800 MG TABLET, is $0.6952 per EA — about 34% below SEVELAMER HCL 800 MG TABLET.
Who manufactures SEVELAMER HCL 800 MG TABLET?
SEVELAMER HCL 800 MG TABLET (NDC 72603014801) is labeled by NorthStar Rx LLC, and CMS classifies it as a generic product.